Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled, Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache and Open Label Extension

Trial Profile

Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled, Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache and Open Label Extension

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2009

At a glance

  • Drugs Tonabersat (Primary)
  • Indications Migraine
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms TEMPUS
  • Sponsors Minster Pharmaceuticals
  • Most Recent Events

    • 24 Oct 2008 Results are expected in the first quarter of 2009, according to information from a Minster Pharmaceuticals media release.
    • 26 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top